ACTIMMUNE® (Interferon gamma-1b) is a biologically manufactured protein that is similar to a protein your body makes naturally.1 The exact way this drug works is not fully understood, but it is thought to work by affecting the function of many different types of cells including cells in the immune system and those that help form your bones.1,2 ACTIMMUNE® is approved by the US Food and Drug Administration to1
- Reduce the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD)
- Delay the time to disease progression in patients with severe, malignant osteopetrosis (SMO)
Explore this website to learn more about CGD, and find more information about ACTIMMUNE®. You can also find helpful information on patient support and other resources.
Important note: Chronic Granulomatous Disease and severe, malignant osteopetrosis are separate and unrelated conditions. Having one does not put you at increased risk for the other.
This information is intended for residents of the United States.